MISRA; Tushar

Patent Applications and Registrations

Patent applications and USPTO patent grants for MISRA; Tushar.The latest application filed is for "maleate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-- dihydro-5h-pyrrolo[3,4-b]pyrazine".

Company Profile

0.15.17

MISRA; Tushar - Norfolk MA
Misra; Tushar - Leesburg VA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
MALEATE SALTS OF 6-(5-CHLORO-2-PYRIDYL)-5-[(4-METHYL-1-PIPERAZINYL)CARBONYLOXY]-7-OXO-6,7-- DIHYDRO-5H-PYRROLO[3,4-b]PYRAZINE App 20150203501 - WILKINSON; H. Scott ; et al.	2015-07-23
Method for treating a sleep disorder with eszopiclone maleate Grant 8,889,685 - Wilkinson , et al. November 18, 2	2014-11-18
Method of decreasing the bitterness of a pharmaceutical dosage form containing zopiclone Grant 8,889,686 - Wilkinson , et al. November 18, 2	2014-11-18
Method for treating anxiety with a dosage form of besylate salts of zopiclone or eszopiclone Grant 8,809,332 - Hsia , et al. August 19, 2	2014-08-19
L-malate Salts Of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-- Dihydro-5h-pyrrolo[3,4-b]pyrazine App 20130296565 - WILKINSON; H. Scott ; et al.	2013-11-07
Besylate Salts of 6-(5-Chloro-2-Pyridyl)-5-[(4-Methyl-1-Piperazinyl)Carbonyloxy]-7-oxo-6,7-- dihydro-5H-Pyrrolo[3,4-b]Pyrazine App 20130289039 - Hsia; Richard ; et al.	2013-10-31
MALEATE SALTS OF 6-(5-CHLORO-2-PYRIDYL)-5-[(4-METHYL-1-PIPERAZINYL)CARBONYLOXY]-7-OXO-6,7-- DIHYDRO-5H-PYRROLO[3,4-b]PYRAZINE App 20130289040 - WILKINSON; H. Scott ; et al.	2013-10-31
Method for treating a sleep disorder with a dosage form of a zopiclone or eszopiclone L-malate salt Grant 8,541,416 - Wilkinson , et al. September 24, 2	2013-09-24
Method for treating a sleep disorder with a dosage form of besylate salts of zopiclone or eszopiclone Grant 8,497,267 - Hsia , et al. July 30, 2	2013-07-30
Method for providing blood levels of eszopiclone with maleate salts Grant 8,497,268 - Wilkinson , et al. July 30, 2	2013-07-30
MALEATE SALTS OF 6-(5-CHLORO-2-PYRIDYL)-5-[(4-METHYL-1-PIPERAZINYL)CARBONYLOXY]-7-OXO-6,7-- DIHYDRO-5H-PYRROLO[3,4-b]PYRAZINE App 20120238580 - Wilkinson; H. Scott ; et al.	2012-09-20
Maleate salts of 6-(5-chloro-2-Pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-- dihydro-5H-pyrrolo[3,4-b]pyrazine Grant 8,268,832 - Wilkinson , et al. September 18, 2	2012-09-18
L-malate salts of 6-(5-chloro-2-Pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-Oxo-6,7-- dihydro-5H-pyrrolo[3,4-b]pyrazine Grant 8,269,005 - Wilkinson , et al. September 18, 2	2012-09-18
L-malate Salts Of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-- Dihydro-5h-pyrrolo[3,4-b]pyrazine App 20120220597 - WILKINSON; H. Scott ; et al.	2012-08-30
Besylate Salts of 6-(5-Chloro-2-Pyridyl)-5-[(4 Methyl-1-Piperazinyl)Carbonyloxy]-7-oxo-6, 7-dihydro-5H-Pyrrolo[3,4-b]Pyrazine App 20120220598 - HSIA; Richard ; et al.	2012-08-30
Maleate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-- dihydro-5H-pyrrolo[3,4-b]pyrazine Grant 8,212,036 - Wilkinson , et al. July 3, 2	2012-07-03
Besylate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-- dihydro-5H-pyrrolo[3,4-b]pyrazine Grant 8,198,278 - Hsia , et al. June 12, 2	2012-06-12
L-malate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-- dihydro-5H-pyrrolo[3,4-b]pyrazine Grant 8,198,277 - Wilkinson , et al. June 12, 2	2012-06-12
Salts Of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-- Oxo-6,7-dihy-dro-5h-pyrrolo[3,4-b]pyrazine App 20110053945 - Wilkinson; H. Scott ; et al.	2011-03-03
PH INDEPENDENT FORMULATIONS OF 6-(5-CHLORO-2-PYRIDYL)-5-[(4-METHYL-1-PIPERAZINYL)CARBONYLOXY]-7-OXO-6,7-- DIHYDRO-5H-PYRROLO[3,4-b]PYRAZINE App 20110009416 - HSIA; Richard ; et al.	2011-01-13
Maleate Salts of 6-(5-Chloro-2-Pyridyl)-5-[(4-Methyl-1-Piperazinyl)Carbonyloxy]-7-oxo-6,7-- dihydro-5H-Pyrrolo[3,4-b]Pyrazine App 20100009995 - Wilkinson; H. Scott ; et al.	2010-01-14
L-Malate Salts of 6-(5-Chloro-2-Pyridyl)-5-[(4-Methyl-1-Piperazinyl)Carbonyloxy]-7-Oxo-6,7-- Dihydro-5H-Pyrrolo[3,4-b]Pyrazine App 20100009994 - Wilkinson; H. Scott ; et al.	2010-01-14
Pacifier With Thin-film Reservoir And Method For Use Thereof App 20090227977 - Fuisz; Richard C. ; et al.	2009-09-10
Maleate Salts of 6-(5-Chloro-2-Pyridyl)-5-[(4-Methyl-1-Piperazinyl)Carbonyloxy]-7-oxo-6,7-- dihydro-5H-Pyrrolo[3,4-b]Pyrazine App 20090215784 - Wilkinson; H. Scott ; et al.	2009-08-27
L-Malate Salts of 6-(5-Chloro-2-Pyridyl)-5-[(4-Methyl-1-Piperazinyl)Carbonyloxy]-7-Oxo-6,7-- Dihydro-5H-Pyrrolo[3,4-b]Pyrazine App 20090209546 - Wilkinson; H. Scott ; et al.	2009-08-20
Besylate Salts of 6-(5-Chloro-2-Pyridyl)-5-[(4-Methyl-1-Piperazinyl)Carbonyloxy]-7-oxo-6,7-- dihydro-5H-Pyrrolo[3,4-b]Pyrazine App 20090209545 - Hsia; Richard ; et al.	2009-08-20
Pacifier with thin-film reservoir and method for use thereof Grant 7,500,984 - Fuisz , et al. March 10, 2	2009-03-10
Treatment of anxiety with eszopiclone App 20080175903 - Hopkins; Seth C. ; et al.	2008-07-24
Pacifier with thin-film reservoir and method for use thereof App 20060058845 - Fuisz; Richard C. ; et al.	2006-03-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.